Skip to main content
Erschienen in: Journal of Neurology 5/2012

01.05.2012 | Review

A differential diagnosis of central nervous system demyelination: beyond multiple sclerosis

verfasst von: Christopher Eckstein, Shiv Saidha, Michael Levy

Erschienen in: Journal of Neurology | Ausgabe 5/2012

Einloggen, um Zugang zu erhalten

Abstract

Although multiple sclerosis (MS) is the most common demyelinating disorder of the central nervous system (CNS), it lacks any definitive diagnostic test. Instead, diagnosis of MS primarily depends upon clinical criteria, supported by abnormalities characteristic of MS on para-clinical investigations including magnetic resonance imaging of the brain and spine, in the absence of an alternative explanation for underlying neurologic symptoms. While many of the potential disorders that may mimic MS in routine clinical practice are either extremely rare, or associated with specific and characteristic distinguishing diagnostic features, some inflammatory demyelinating disorders of the CNS may be particularly challenging to distinguish from MS, especially during initial presentation. In particular, acute disseminated encephalomyelitis, neuromyelitis optica, and idiopathic transverse myelitis may closely resemble MS, impeding prompt and accurate diagnosis. In this review, we describe the clinical features, diagnosis, pathology, and treatment of these other CNS demyelinating disorders. In addition, we review relevant features of other CNS inflammatory disorders that may mimic MS, including Sjögren’s syndrome, systemic lupus erythematosus, Behçet’s disease, and primary CNS vasculitis.
Literatur
1.
Zurück zum Zitat Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, Fujihara K, Havrdova E, Hutchinson M, Kappos L, Lublin FD, Montalban X, O’Connor P, Sandberg-Wollheim M, Thompson AJ, Waubant E, Weinshenker B, Wolinsky JS (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69(2):292–302. doi:10.1002/ana.22366 PubMedCrossRef Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, Fujihara K, Havrdova E, Hutchinson M, Kappos L, Lublin FD, Montalban X, O’Connor P, Sandberg-Wollheim M, Thompson AJ, Waubant E, Weinshenker B, Wolinsky JS (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69(2):292–302. doi:10.​1002/​ana.​22366 PubMedCrossRef
2.
Zurück zum Zitat Miller DH, Weinshenker BG, Filippi M, Banwell BL, Cohen JA, Freedman MS, Galetta SL, Hutchinson M, Johnson RT, Kappos L, Kira J, Lublin FD, McFarland HF, Montalban X, Panitch H, Richert JR, Reingold SC, Polman CH (2008) Differential diagnosis of suspected multiple sclerosis: a consensus approach. Mult Scler 14(9):1157–1174. doi:10.1177/1352458508096878 PubMedCrossRef Miller DH, Weinshenker BG, Filippi M, Banwell BL, Cohen JA, Freedman MS, Galetta SL, Hutchinson M, Johnson RT, Kappos L, Kira J, Lublin FD, McFarland HF, Montalban X, Panitch H, Richert JR, Reingold SC, Polman CH (2008) Differential diagnosis of suspected multiple sclerosis: a consensus approach. Mult Scler 14(9):1157–1174. doi:10.​1177/​1352458508096878​ PubMedCrossRef
3.
Zurück zum Zitat de Seze J (2007) Multiple sclerosis: clinical aspects, acute disseminated encephalomyelitis, neuromyelitis optica and other inflammatory variants. Rev Neurol (Paris) 163(6–7):647–650CrossRef de Seze J (2007) Multiple sclerosis: clinical aspects, acute disseminated encephalomyelitis, neuromyelitis optica and other inflammatory variants. Rev Neurol (Paris) 163(6–7):647–650CrossRef
4.
Zurück zum Zitat Torisu H, Kira R, Ishizaki Y, Sanefuji M, Yamaguchi Y, Yasumoto S, Murakami Y, Shimono M, Nagamitsu S, Masuzaki M, Amamoto M, Kondo R, Uozumi T, Aibe M, Gondo K, Hanai T, Hirose S, Matsuishi T, Shirahata A, Mitsudome A, Hara T (2010) Clinical study of childhood acute disseminated encephalomyelitis, multiple sclerosis, and acute transverse myelitis in Fukuoka Prefecture, Japan. Brain Dev 32(6):454–462. doi:10.1016/j.braindev.2009.10.006 PubMedCrossRef Torisu H, Kira R, Ishizaki Y, Sanefuji M, Yamaguchi Y, Yasumoto S, Murakami Y, Shimono M, Nagamitsu S, Masuzaki M, Amamoto M, Kondo R, Uozumi T, Aibe M, Gondo K, Hanai T, Hirose S, Matsuishi T, Shirahata A, Mitsudome A, Hara T (2010) Clinical study of childhood acute disseminated encephalomyelitis, multiple sclerosis, and acute transverse myelitis in Fukuoka Prefecture, Japan. Brain Dev 32(6):454–462. doi:10.​1016/​j.​braindev.​2009.​10.​006 PubMedCrossRef
5.
Zurück zum Zitat Tselis A, Lisak R (2005) Acute disseminated encephalomyelitis. In: Antel JP, Birnbaum G, Hartung HP, Vincent A (eds) Clinical neuroimmunology. Oxford University Press, New York, pp 147–171 Tselis A, Lisak R (2005) Acute disseminated encephalomyelitis. In: Antel JP, Birnbaum G, Hartung HP, Vincent A (eds) Clinical neuroimmunology. Oxford University Press, New York, pp 147–171
9.
Zurück zum Zitat Kuker W, Ruff J, Gaertner S, Mehnert F, Mader I, Nagele T (2004) Modern MRI tools for the characterization of acute demyelinating lesions: value of chemical shift and diffusion-weighted imaging. Neuroradiology 46(6):421–426. doi:10.1007/s00234-004-1203-5 PubMedCrossRef Kuker W, Ruff J, Gaertner S, Mehnert F, Mader I, Nagele T (2004) Modern MRI tools for the characterization of acute demyelinating lesions: value of chemical shift and diffusion-weighted imaging. Neuroradiology 46(6):421–426. doi:10.​1007/​s00234-004-1203-5 PubMedCrossRef
11.
Zurück zum Zitat Ben Sira L, Miller E, Artzi M, Fattal-Valevski A, Constantini S, Ben Bashat D (2010) 1H-MRS for the diagnosis of acute disseminated encephalomyelitis: insight into the acute-disease stage. Pediatr Radiol 40(1):106–113. doi:10.1007/s00247-009-1372-9 PubMedCrossRef Ben Sira L, Miller E, Artzi M, Fattal-Valevski A, Constantini S, Ben Bashat D (2010) 1H-MRS for the diagnosis of acute disseminated encephalomyelitis: insight into the acute-disease stage. Pediatr Radiol 40(1):106–113. doi:10.​1007/​s00247-009-1372-9 PubMedCrossRef
12.
13.
Zurück zum Zitat Franciotta D, Columba-Cabezas S, Andreoni L, Ravaglia S, Jarius S, Romagnolo S, Tavazzi E, Bergamaschi R, Zardini E, Aloisi F, Marchioni E (2008) Oligoclonal IgG band patterns in inflammatory demyelinating human and mouse diseases. J Neuroimmunol 200(1–2):125–128. doi:10.1016/j.jneuroim.2008.06.004 PubMedCrossRef Franciotta D, Columba-Cabezas S, Andreoni L, Ravaglia S, Jarius S, Romagnolo S, Tavazzi E, Bergamaschi R, Zardini E, Aloisi F, Marchioni E (2008) Oligoclonal IgG band patterns in inflammatory demyelinating human and mouse diseases. J Neuroimmunol 200(1–2):125–128. doi:10.​1016/​j.​jneuroim.​2008.​06.​004 PubMedCrossRef
15.
Zurück zum Zitat Lalive PH, Hausler MG, Maurey H, Mikaeloff Y, Tardieu M, Wiendl H, Schroeter M, Hartung HP, Kieseier BC, Menge T (2011) Highly reactive anti-myelin oligodendrocyte glycoprotein antibodies differentiate demyelinating diseases from viral encephalitis in children. Mult Scler 17(3):297–302. doi:10.1177/1352458510389220 PubMedCrossRef Lalive PH, Hausler MG, Maurey H, Mikaeloff Y, Tardieu M, Wiendl H, Schroeter M, Hartung HP, Kieseier BC, Menge T (2011) Highly reactive anti-myelin oligodendrocyte glycoprotein antibodies differentiate demyelinating diseases from viral encephalitis in children. Mult Scler 17(3):297–302. doi:10.​1177/​1352458510389220​ PubMedCrossRef
17.
Zurück zum Zitat Rodriguez M, Powell H, Lampert W (1983) Demyelination and leukodystrophy in the clinical neurosciences. In: Rosenberg R, Schoclet S (eds) Neuropathology, vol III. Churchill Livinstone, New York, pp 419–443 Rodriguez M, Powell H, Lampert W (1983) Demyelination and leukodystrophy in the clinical neurosciences. In: Rosenberg R, Schoclet S (eds) Neuropathology, vol III. Churchill Livinstone, New York, pp 419–443
18.
Zurück zum Zitat Stricker RB, Miller RG, Kiprov DD (1992) Role of plasmapheresis in acute disseminated (post-infectious) encephalomyelitis. J Clin Apher 7(4):173–179PubMedCrossRef Stricker RB, Miller RG, Kiprov DD (1992) Role of plasmapheresis in acute disseminated (post-infectious) encephalomyelitis. J Clin Apher 7(4):173–179PubMedCrossRef
19.
Zurück zum Zitat Straub J, Chofflon M, Delavelle J (1997) Early high-dose intravenous methylprednisolone in acute disseminated encephalomyelitis: a successful recovery. Neurology 49(4):1145–1147PubMedCrossRef Straub J, Chofflon M, Delavelle J (1997) Early high-dose intravenous methylprednisolone in acute disseminated encephalomyelitis: a successful recovery. Neurology 49(4):1145–1147PubMedCrossRef
20.
Zurück zum Zitat Dalakas MC (1998) Mechanism of action of intravenous immunoglobulin and therapeutic considerations in the treatment of autoimmune neurologic diseases. Neurology 51(6 Suppl 5):S2–S8PubMedCrossRef Dalakas MC (1998) Mechanism of action of intravenous immunoglobulin and therapeutic considerations in the treatment of autoimmune neurologic diseases. Neurology 51(6 Suppl 5):S2–S8PubMedCrossRef
21.
Zurück zum Zitat Sahlas DJ, Miller SP, Guerin M, Veilleux M, Francis G (2000) Treatment of acute disseminated encephalomyelitis with intravenous immunoglobulin. Neurology 54(6):1370–1372PubMedCrossRef Sahlas DJ, Miller SP, Guerin M, Veilleux M, Francis G (2000) Treatment of acute disseminated encephalomyelitis with intravenous immunoglobulin. Neurology 54(6):1370–1372PubMedCrossRef
22.
Zurück zum Zitat Kleiman M, Brunquell P (1995) Acute disseminated encephalomyelitis: response to intravenous immunoglobulin. J Child Neurol 10(6):481–483PubMedCrossRef Kleiman M, Brunquell P (1995) Acute disseminated encephalomyelitis: response to intravenous immunoglobulin. J Child Neurol 10(6):481–483PubMedCrossRef
23.
Zurück zum Zitat Bala B, Banwell B (2010) Cognitive and behavioural outcomes in individuals with a history of childhood acute disseminated encephalomyelitis. 62nd Annual Meeting, American Academy of Neurology, Toronto, pp IN2-2.005 Bala B, Banwell B (2010) Cognitive and behavioural outcomes in individuals with a history of childhood acute disseminated encephalomyelitis. 62nd Annual Meeting, American Academy of Neurology, Toronto, pp IN2-2.005
24.
Zurück zum Zitat Donmez FY, Aslan H, Coskun M (2009) Evaluation of possible prognostic factors of fulminant acute disseminated encephalomyelitis (ADEM) on magnetic resonance imaging with fluid-attenuated inversion recovery (FLAIR) and diffusion-weighted imaging. Acta Radiol 50(3):334–339. doi:10.1080/02841850902736617 PubMedCrossRef Donmez FY, Aslan H, Coskun M (2009) Evaluation of possible prognostic factors of fulminant acute disseminated encephalomyelitis (ADEM) on magnetic resonance imaging with fluid-attenuated inversion recovery (FLAIR) and diffusion-weighted imaging. Acta Radiol 50(3):334–339. doi:10.​1080/​0284185090273661​7 PubMedCrossRef
26.
Zurück zum Zitat Schwarz S, Mohr A, Knauth M, Wildemann B, Storch-Hagenlocher B (2001) Acute disseminated encephalomyelitis: a follow-up study of 40 adult patients. Neurology 56(10):1313–1318PubMedCrossRef Schwarz S, Mohr A, Knauth M, Wildemann B, Storch-Hagenlocher B (2001) Acute disseminated encephalomyelitis: a follow-up study of 40 adult patients. Neurology 56(10):1313–1318PubMedCrossRef
30.
Zurück zum Zitat Wingerchuk DM, Hogancamp WF, O’Brien PC, Weinshenker BG (1999) The clinical course of neuromyelitis optica (Devic’s syndrome). Neurology 53(5):1107–1114PubMedCrossRef Wingerchuk DM, Hogancamp WF, O’Brien PC, Weinshenker BG (1999) The clinical course of neuromyelitis optica (Devic’s syndrome). Neurology 53(5):1107–1114PubMedCrossRef
31.
Zurück zum Zitat Ghezzi A, Bergamaschi R, Martinelli V, Trojano M, Tola MR, Merelli E, Mancardi L, Gallo P, Filippi M, Zaffaroni M, Comi G (2004) Clinical characteristics, course and prognosis of relapsing Devic’s Neuromyelitis Optica. J Neurol 251(1):47–52. doi:10.1007/s00415-004-0271-0 PubMedCrossRef Ghezzi A, Bergamaschi R, Martinelli V, Trojano M, Tola MR, Merelli E, Mancardi L, Gallo P, Filippi M, Zaffaroni M, Comi G (2004) Clinical characteristics, course and prognosis of relapsing Devic’s Neuromyelitis Optica. J Neurol 251(1):47–52. doi:10.​1007/​s00415-004-0271-0 PubMedCrossRef
34.
35.
Zurück zum Zitat Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K, Nakashima I, Weinshenker BG (2004) A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364(9451):2106–2112. doi:10.1016/S0140-6736(04)17551-X PubMedCrossRef Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K, Nakashima I, Weinshenker BG (2004) A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364(9451):2106–2112. doi:10.​1016/​S0140-6736(04)17551-X PubMedCrossRef
36.
Zurück zum Zitat Eckstein C, Syc S, Saidha S (2011) Differential diagnosis of longitudinally extensive transverse myelitis in adults. Eur Neurol J 3(1):27–39 Eckstein C, Syc S, Saidha S (2011) Differential diagnosis of longitudinally extensive transverse myelitis in adults. Eur Neurol J 3(1):27–39
37.
Zurück zum Zitat Matsuoka T, Matsushita T, Osoegawa M, Ochi H, Kawano Y, Mihara F, Ohyagi Y, Kira J (2008) Heterogeneity and continuum of multiple sclerosis in Japanese according to magnetic resonance imaging findings. J Neurol Sci 266(1–2):115–125PubMedCrossRef Matsuoka T, Matsushita T, Osoegawa M, Ochi H, Kawano Y, Mihara F, Ohyagi Y, Kira J (2008) Heterogeneity and continuum of multiple sclerosis in Japanese according to magnetic resonance imaging findings. J Neurol Sci 266(1–2):115–125PubMedCrossRef
38.
39.
Zurück zum Zitat Nakashima I, Fujihara K, Miyazawa I, Misu T, Narikawa K, Nakamura M, Watanabe S, Takahashi T, Nishiyama S, Shiga Y, Sato S, Weinshenker BG, Itoyama Y (2006) Clinical and MRI features of Japanese patients with multiple sclerosis positive for NMO-IgG. J Neurol Neurosurg Psychiatry 77(9):1073–1075. doi:10.1136/jnnp.2005.080390 PubMedCrossRef Nakashima I, Fujihara K, Miyazawa I, Misu T, Narikawa K, Nakamura M, Watanabe S, Takahashi T, Nishiyama S, Shiga Y, Sato S, Weinshenker BG, Itoyama Y (2006) Clinical and MRI features of Japanese patients with multiple sclerosis positive for NMO-IgG. J Neurol Neurosurg Psychiatry 77(9):1073–1075. doi:10.​1136/​jnnp.​2005.​080390 PubMedCrossRef
40.
Zurück zum Zitat Weinshenker BG, Wingerchuk DM, Nakashima I, Fujihara K, Lennon VA (2006) OSMS is NMO, but not MS: proven clinically and pathologically. Lancet Neurol 5(2):110–111PubMedCrossRef Weinshenker BG, Wingerchuk DM, Nakashima I, Fujihara K, Lennon VA (2006) OSMS is NMO, but not MS: proven clinically and pathologically. Lancet Neurol 5(2):110–111PubMedCrossRef
41.
Zurück zum Zitat Kira J (2008) Neuromyelitis optica and Asian phenotype of multiple sclerosis. Ann N Y Acad Sci 1142:58–71PubMedCrossRef Kira J (2008) Neuromyelitis optica and Asian phenotype of multiple sclerosis. Ann N Y Acad Sci 1142:58–71PubMedCrossRef
42.
Zurück zum Zitat Lucchinetti CF, Mandler RN, McGavern D, Bruck W, Gleich G, Ransohoff RM, Trebst C, Weinshenker B, Wingerchuk D, Parisi JE, Lassmann H (2002) A role for humoral mechanisms in the pathogenesis of Devic’s neuromyelitis optica. Brain 125(Pt 7):1450–1461PubMedCrossRef Lucchinetti CF, Mandler RN, McGavern D, Bruck W, Gleich G, Ransohoff RM, Trebst C, Weinshenker B, Wingerchuk D, Parisi JE, Lassmann H (2002) A role for humoral mechanisms in the pathogenesis of Devic’s neuromyelitis optica. Brain 125(Pt 7):1450–1461PubMedCrossRef
43.
Zurück zum Zitat Roemer SF, Parisi JE, Lennon VA, Benarroch EE, Lassmann H, Bruck W, Mandler RN, Weinshenker BG, Pittock SJ, Wingerchuk DM, Lucchinetti CF (2007) Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain 130(Pt 5):1194–1205. doi:10.1093/brain/awl371 PubMedCrossRef Roemer SF, Parisi JE, Lennon VA, Benarroch EE, Lassmann H, Bruck W, Mandler RN, Weinshenker BG, Pittock SJ, Wingerchuk DM, Lucchinetti CF (2007) Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain 130(Pt 5):1194–1205. doi:10.​1093/​brain/​awl371 PubMedCrossRef
44.
Zurück zum Zitat Misu T, Fujihara K, Kakita A, Konno H, Nakamura M, Watanabe S, Takahashi T, Nakashima I, Takahashi H, Itoyama Y (2007) Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis. Brain 130(Pt 5):1224–1234. doi:10.1093/brain/awm047 PubMedCrossRef Misu T, Fujihara K, Kakita A, Konno H, Nakamura M, Watanabe S, Takahashi T, Nakashima I, Takahashi H, Itoyama Y (2007) Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis. Brain 130(Pt 5):1224–1234. doi:10.​1093/​brain/​awm047 PubMedCrossRef
45.
Zurück zum Zitat Papeix C, Vidal JS, de Seze J, Pierrot-Deseilligny C, Tourbah A, Stankoff B, Lebrun C, Moreau T, Vermersch P, Fontaine B, Lyon-Caen O, Gout O (2007) Immunosuppressive therapy is more effective than interferon in neuromyelitis optica. Mult Scler 13(2):256–259. doi:10.1177/1352458506070732 PubMedCrossRef Papeix C, Vidal JS, de Seze J, Pierrot-Deseilligny C, Tourbah A, Stankoff B, Lebrun C, Moreau T, Vermersch P, Fontaine B, Lyon-Caen O, Gout O (2007) Immunosuppressive therapy is more effective than interferon in neuromyelitis optica. Mult Scler 13(2):256–259. doi:10.​1177/​1352458506070732​ PubMedCrossRef
47.
Zurück zum Zitat Capobianco M, Malucchi S, di Sapio A, Gilli F, Sala A, Bottero R, Marnetto F, Doriguzzi Bozzo C, Bertolotto A (2007) Variable responses to rituximab treatment in neuromyelitis optica (Devic’s disease). Neurol Sci 28(4):209–211. doi:10.1007/s10072-007-0823-z PubMedCrossRef Capobianco M, Malucchi S, di Sapio A, Gilli F, Sala A, Bottero R, Marnetto F, Doriguzzi Bozzo C, Bertolotto A (2007) Variable responses to rituximab treatment in neuromyelitis optica (Devic’s disease). Neurol Sci 28(4):209–211. doi:10.​1007/​s10072-007-0823-z PubMedCrossRef
48.
Zurück zum Zitat Kim SH, Kim W, Li XF, Jung IJ, Kim HJ (2011) Repeated treatment with rituximab based on the assessment of peripheral circulating memory B cells in patients with relapsing neuromyelitis optica over 2 years. Arch Neurol. doi:10.1001/archneurol.2011.154 Kim SH, Kim W, Li XF, Jung IJ, Kim HJ (2011) Repeated treatment with rituximab based on the assessment of peripheral circulating memory B cells in patients with relapsing neuromyelitis optica over 2 years. Arch Neurol. doi:10.​1001/​archneurol.​2011.​154
49.
Zurück zum Zitat Pellkofer HL, Krumbholz M, Berthele A, Hemmer B, Gerdes LA, Havla J, Bittner R, Canis M, Meinl E, Hohlfeld R, Kuempfel T (2011) Long-term follow-up of patients with neuromyelitis optica after repeated therapy with rituximab. Neurology 76(15):1310–1315. doi:10.1212/WNL.0b013e3182152881 PubMedCrossRef Pellkofer HL, Krumbholz M, Berthele A, Hemmer B, Gerdes LA, Havla J, Bittner R, Canis M, Meinl E, Hohlfeld R, Kuempfel T (2011) Long-term follow-up of patients with neuromyelitis optica after repeated therapy with rituximab. Neurology 76(15):1310–1315. doi:10.​1212/​WNL.​0b013e3182152881​ PubMedCrossRef
52.
Zurück zum Zitat Duddy M, Niino M, Adatia F, Hebert S, Freedman M, Atkins H, Kim HJ, Bar-Or A (2007) Distinct effector cytokine profiles of memory and naive human B cell subsets and implication in multiple sclerosis. J Immunol 178(10):6092–6099PubMed Duddy M, Niino M, Adatia F, Hebert S, Freedman M, Atkins H, Kim HJ, Bar-Or A (2007) Distinct effector cytokine profiles of memory and naive human B cell subsets and implication in multiple sclerosis. J Immunol 178(10):6092–6099PubMed
54.
Zurück zum Zitat Shimizu Y, Yokoyama K, Misu T, Takahashi T, Fujihara K, Kikuchi S, Itoyama Y, Iwata M (2008) Development of extensive brain lesions following interferon beta therapy in relapsing neuromyelitis optica and longitudinally extensive myelitis. J Neurol 255(2):305–307. doi:10.1007/s00415-007-0730-5 PubMedCrossRef Shimizu Y, Yokoyama K, Misu T, Takahashi T, Fujihara K, Kikuchi S, Itoyama Y, Iwata M (2008) Development of extensive brain lesions following interferon beta therapy in relapsing neuromyelitis optica and longitudinally extensive myelitis. J Neurol 255(2):305–307. doi:10.​1007/​s00415-007-0730-5 PubMedCrossRef
55.
Zurück zum Zitat Pittock SJ, Lennon VA, de Seze J, Vermersch P, Homburger HA, Wingerchuk DM, Lucchinetti CF, Zephir H, Moder K, Weinshenker BG (2008) Neuromyelitis optica and non organ-specific autoimmunity. Arch Neurol 65(1):78–83. doi:10.1001/archneurol.2007.17 PubMedCrossRef Pittock SJ, Lennon VA, de Seze J, Vermersch P, Homburger HA, Wingerchuk DM, Lucchinetti CF, Zephir H, Moder K, Weinshenker BG (2008) Neuromyelitis optica and non organ-specific autoimmunity. Arch Neurol 65(1):78–83. doi:10.​1001/​archneurol.​2007.​17 PubMedCrossRef
57.
Zurück zum Zitat Transverse Myelitis Consortium Working Group (2002) Proposed diagnostic criteria, nosology of acute transverse myelitis. Neurology 59(4):499–505CrossRef Transverse Myelitis Consortium Working Group (2002) Proposed diagnostic criteria, nosology of acute transverse myelitis. Neurology 59(4):499–505CrossRef
60.
Zurück zum Zitat de Seze J, Lanctin C, Lebrun C, Malikova I, Papeix C, Wiertlewski S, Pelletier J, Gout O, Clerc C, Moreau C, Defer G, Edan G, Dubas F, Vermersch P (2005) Idiopathic acute transverse myelitis: application of the recent diagnostic criteria. Neurology 65(12):1950–1953. doi:10.1212/01.wnl.0000188896.48308.26 PubMedCrossRef de Seze J, Lanctin C, Lebrun C, Malikova I, Papeix C, Wiertlewski S, Pelletier J, Gout O, Clerc C, Moreau C, Defer G, Edan G, Dubas F, Vermersch P (2005) Idiopathic acute transverse myelitis: application of the recent diagnostic criteria. Neurology 65(12):1950–1953. doi:10.​1212/​01.​wnl.​0000188896.​48308.​26 PubMedCrossRef
61.
Zurück zum Zitat Bruna J, Martinez-Yelamos S, Martinez-Yelamos A, Rubio F, Arbizu T (2006) Idiopathic acute transverse myelitis: a clinical study and prognostic markers in 45 cases. Mult Scler 12(2):169–173PubMedCrossRef Bruna J, Martinez-Yelamos S, Martinez-Yelamos A, Rubio F, Arbizu T (2006) Idiopathic acute transverse myelitis: a clinical study and prognostic markers in 45 cases. Mult Scler 12(2):169–173PubMedCrossRef
62.
Zurück zum Zitat Alvarenga MP, Thuler LC, Neto SP, Vasconcelos CC, Camargo SG, Papais-Alvarenga RM (2010) The clinical course of idiopathic acute transverse myelitis in patients from Rio de Janeiro. J Neurol 257(6):992–998. doi:10.1007/s00415-009-5450-6 PubMedCrossRef Alvarenga MP, Thuler LC, Neto SP, Vasconcelos CC, Camargo SG, Papais-Alvarenga RM (2010) The clinical course of idiopathic acute transverse myelitis in patients from Rio de Janeiro. J Neurol 257(6):992–998. doi:10.​1007/​s00415-009-5450-6 PubMedCrossRef
64.
66.
Zurück zum Zitat Morrissey SP, Miller DH, Kendall BE, Kingsley DP, Kelly MA, Francis DA, MacManus DG, McDonald WI (1993) The significance of brain magnetic resonance imaging abnormalities at presentation with clinically isolated syndromes suggestive of multiple sclerosis: a 5-year follow-up study. Brain 116(Pt 1):135–146PubMedCrossRef Morrissey SP, Miller DH, Kendall BE, Kingsley DP, Kelly MA, Francis DA, MacManus DG, McDonald WI (1993) The significance of brain magnetic resonance imaging abnormalities at presentation with clinically isolated syndromes suggestive of multiple sclerosis: a 5-year follow-up study. Brain 116(Pt 1):135–146PubMedCrossRef
67.
Zurück zum Zitat Bashir K, Whitaker JN (2000) Importance of para-clinical and CSF studies in the diagnosis of MS in patients presenting with partial cervical transverse myelopathy and negative cranial MRI. Mult Scler 6(5):312–316PubMed Bashir K, Whitaker JN (2000) Importance of para-clinical and CSF studies in the diagnosis of MS in patients presenting with partial cervical transverse myelopathy and negative cranial MRI. Mult Scler 6(5):312–316PubMed
71.
Zurück zum Zitat Lipton HL, Teasdall RD (1973) Acute transverse myelopathy in adults: a follow-up study. Arch Neurol 28(4):252–257PubMedCrossRef Lipton HL, Teasdall RD (1973) Acute transverse myelopathy in adults: a follow-up study. Arch Neurol 28(4):252–257PubMedCrossRef
72.
Zurück zum Zitat Kaplin AI, Deshpande DM, Scott E, Krishnan C, Carmen JS, Shats I, Martinez T, Drummond J, Dike S, Pletnikov M, Keswani SC, Moran TH, Pardo CA, Calabresi PA, Kerr DA (2005) IL-6 induces regionally selective spinal cord injury in patients with the neuroinflammatory disorder transverse myelitis. J Clin Invest 115(10):2731–2741. doi:10.1172/JCI25141 PubMedCrossRef Kaplin AI, Deshpande DM, Scott E, Krishnan C, Carmen JS, Shats I, Martinez T, Drummond J, Dike S, Pletnikov M, Keswani SC, Moran TH, Pardo CA, Calabresi PA, Kerr DA (2005) IL-6 induces regionally selective spinal cord injury in patients with the neuroinflammatory disorder transverse myelitis. J Clin Invest 115(10):2731–2741. doi:10.​1172/​JCI25141 PubMedCrossRef
75.
Zurück zum Zitat Weinshenker BG, O’Brien PC, Petterson TM, Noseworthy JH, Lucchinetti CF, Dodick DW, Pineda AA, Stevens LN, Rodriguez M (1999) A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease. Ann Neurol 46(6):878–886PubMedCrossRef Weinshenker BG, O’Brien PC, Petterson TM, Noseworthy JH, Lucchinetti CF, Dodick DW, Pineda AA, Stevens LN, Rodriguez M (1999) A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease. Ann Neurol 46(6):878–886PubMedCrossRef
76.
77.
Zurück zum Zitat Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS, Pillemer SR, Talal N, Weisman MH (2002) Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61(6):554–558PubMedCrossRef Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS, Pillemer SR, Talal N, Weisman MH (2002) Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61(6):554–558PubMedCrossRef
78.
Zurück zum Zitat Kim SM, Waters P, Vincent A, Kim SY, Kim HJ, Hong YH, Park KS, Min JH, Sung JJ, Lee KW (2009) Sjögren’s syndrome myelopathy: spinal cord involvement in Sjögren’s syndrome might be a manifestation of neuromyelitis optica. Mult Scler 15(9):1062–1068. doi:10.1177/1352458509106636 PubMedCrossRef Kim SM, Waters P, Vincent A, Kim SY, Kim HJ, Hong YH, Park KS, Min JH, Sung JJ, Lee KW (2009) Sjögren’s syndrome myelopathy: spinal cord involvement in Sjögren’s syndrome might be a manifestation of neuromyelitis optica. Mult Scler 15(9):1062–1068. doi:10.​1177/​1352458509106636​ PubMedCrossRef
79.
Zurück zum Zitat Kim SM, Waters P, Vincent A, Kim SY, Kim HJ, Hong YH, Park KS, Min JH, Sung JJ, Lee KW (2009) Sjögren’s syndrome myelopathy: spinal cord involvement in Sjögren’s syndrome might be a manifestation of neuromyelitis optica. Mult Scler 15(9):1062–1068PubMedCrossRef Kim SM, Waters P, Vincent A, Kim SY, Kim HJ, Hong YH, Park KS, Min JH, Sung JJ, Lee KW (2009) Sjögren’s syndrome myelopathy: spinal cord involvement in Sjögren’s syndrome might be a manifestation of neuromyelitis optica. Mult Scler 15(9):1062–1068PubMedCrossRef
80.
Zurück zum Zitat Pericot I, Brieva L, Tintore M, Rio J, Sastre-Garriga J, Nos C, Montalban X (2003) Myelopathy in seronegative Sjögren syndrome and/or primary progressive multiple sclerosis. Mult Scler 9(3):256–259PubMedCrossRef Pericot I, Brieva L, Tintore M, Rio J, Sastre-Garriga J, Nos C, Montalban X (2003) Myelopathy in seronegative Sjögren syndrome and/or primary progressive multiple sclerosis. Mult Scler 9(3):256–259PubMedCrossRef
81.
Zurück zum Zitat Delalande S, de Seze J, Fauchais AL, Hachulla E, Stojkovic T, Ferriby D, Dubucquoi S, Pruvo JP, Vermersch P, Hatron PY (2004) Neurologic manifestations in primary Sjögren syndrome: a study of 82 patients. Medicine (Baltimore) 83(5):280–291CrossRef Delalande S, de Seze J, Fauchais AL, Hachulla E, Stojkovic T, Ferriby D, Dubucquoi S, Pruvo JP, Vermersch P, Hatron PY (2004) Neurologic manifestations in primary Sjögren syndrome: a study of 82 patients. Medicine (Baltimore) 83(5):280–291CrossRef
82.
Zurück zum Zitat Binder A, Snaith ML, Isenberg D (1988) Sjögren’s syndrome: a study of its neurological complications. Br J Rheumatol 27(4):275–280PubMedCrossRef Binder A, Snaith ML, Isenberg D (1988) Sjögren’s syndrome: a study of its neurological complications. Br J Rheumatol 27(4):275–280PubMedCrossRef
83.
Zurück zum Zitat Pillemer SR, Matteson EL, Jacobsson LT, Martens PB, Melton LJ 3rd, O’Fallon WM, Fox PC (2001) Incidence of physician-diagnosed primary Sjögren syndrome in residents of Olmsted County, Minnesota. Mayo Clin Proc 76(6):593–599PubMed Pillemer SR, Matteson EL, Jacobsson LT, Martens PB, Melton LJ 3rd, O’Fallon WM, Fox PC (2001) Incidence of physician-diagnosed primary Sjögren syndrome in residents of Olmsted County, Minnesota. Mayo Clin Proc 76(6):593–599PubMed
84.
Zurück zum Zitat Alexander EL, Malinow K, Lejewski JE, Jerdan MS, Provost TT, Alexander GE (1986) Primary Sjögren’s syndrome with central nervous system disease mimicking multiple sclerosis. Ann Intern Med 104(3):323–330PubMed Alexander EL, Malinow K, Lejewski JE, Jerdan MS, Provost TT, Alexander GE (1986) Primary Sjögren’s syndrome with central nervous system disease mimicking multiple sclerosis. Ann Intern Med 104(3):323–330PubMed
85.
Zurück zum Zitat Williams CS, Butler E, Roman GC (2001) Treatment of myelopathy in Sjögren syndrome with a combination of prednisone and cyclophosphamide. Arch Neurol 58(5):815–819PubMedCrossRef Williams CS, Butler E, Roman GC (2001) Treatment of myelopathy in Sjögren syndrome with a combination of prednisone and cyclophosphamide. Arch Neurol 58(5):815–819PubMedCrossRef
88.
Zurück zum Zitat Ellis SG, Verity MA (1979) Central nervous system involvement in systemic lupus erythematosus: a review of neuropathologic findings in 57 cases, 1955–1977. Semin Arthritis Rheum 8(3):212–221PubMedCrossRef Ellis SG, Verity MA (1979) Central nervous system involvement in systemic lupus erythematosus: a review of neuropathologic findings in 57 cases, 1955–1977. Semin Arthritis Rheum 8(3):212–221PubMedCrossRef
89.
Zurück zum Zitat Kovacs B, Lafferty TL, Brent LH, DeHoratius RJ (2000) Transverse myelopathy in systemic lupus erythematosus: an analysis of 14 cases and review of the literature. Ann Rheum Dis 59(2):120–124PubMedCrossRef Kovacs B, Lafferty TL, Brent LH, DeHoratius RJ (2000) Transverse myelopathy in systemic lupus erythematosus: an analysis of 14 cases and review of the literature. Ann Rheum Dis 59(2):120–124PubMedCrossRef
90.
Zurück zum Zitat Sanna G, Bertolaccini ML, Cuadrado MJ, Laing H, Khamashta MA, Mathieu A, Hughes GR (2003) Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies. J Rheumatol 30(5):985–992PubMed Sanna G, Bertolaccini ML, Cuadrado MJ, Laing H, Khamashta MA, Mathieu A, Hughes GR (2003) Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies. J Rheumatol 30(5):985–992PubMed
91.
Zurück zum Zitat Espinosa G, Mendizabal A, Minguez S, Ramo-Tello C, Capellades J, Olive A, Cervera R (2010) Transverse myelitis affecting more than 4 spinal segments associated with systemic lupus erythematosus: clinical, immunological, and radiological characteristics of 22 patients. Semin Arthritis Rheum 39(4):246–256. doi:10.1016/j.semarthrit.2008.09.002 PubMedCrossRef Espinosa G, Mendizabal A, Minguez S, Ramo-Tello C, Capellades J, Olive A, Cervera R (2010) Transverse myelitis affecting more than 4 spinal segments associated with systemic lupus erythematosus: clinical, immunological, and radiological characteristics of 22 patients. Semin Arthritis Rheum 39(4):246–256. doi:10.​1016/​j.​semarthrit.​2008.​09.​002 PubMedCrossRef
92.
Zurück zum Zitat Sherer Y, Hassin S, Shoenfeld Y, Levy Y, Livneh A, Ohry A, Langevitz P (2002) Transverse myelitis in patients with antiphospholipid antibodies–the importance of early diagnosis and treatment. Clin Rheumatol 21(3):207–210PubMedCrossRef Sherer Y, Hassin S, Shoenfeld Y, Levy Y, Livneh A, Ohry A, Langevitz P (2002) Transverse myelitis in patients with antiphospholipid antibodies–the importance of early diagnosis and treatment. Clin Rheumatol 21(3):207–210PubMedCrossRef
94.
Zurück zum Zitat Creamer P, Kirwan J (1992) Seronegative systemic lupus erythematosus. Br J Rheumatol 31(9):619–622PubMedCrossRef Creamer P, Kirwan J (1992) Seronegative systemic lupus erythematosus. Br J Rheumatol 31(9):619–622PubMedCrossRef
96.
Zurück zum Zitat Propper DJ, Bucknall RC (1989) Acute transverse myelopathy complicating systemic lupus erythematosus. Ann Rheum Dis 48(6):512–515PubMedCrossRef Propper DJ, Bucknall RC (1989) Acute transverse myelopathy complicating systemic lupus erythematosus. Ann Rheum Dis 48(6):512–515PubMedCrossRef
97.
Zurück zum Zitat Appenzeller S, Vasconcelos Faria A, Li LM, Costallat LT, Cendes F (2008) Quantitative magnetic resonance imaging analyses and clinical significance of hyperintense white matter lesions in systemic lupus erythematosus patients. Ann Neurol 64(6):635–643. doi:10.1002/ana.21483 PubMedCrossRef Appenzeller S, Vasconcelos Faria A, Li LM, Costallat LT, Cendes F (2008) Quantitative magnetic resonance imaging analyses and clinical significance of hyperintense white matter lesions in systemic lupus erythematosus patients. Ann Neurol 64(6):635–643. doi:10.​1002/​ana.​21483 PubMedCrossRef
98.
Zurück zum Zitat Graham JW, Jan W (2003) MRI and the brain in systemic lupus erythematosus. Lupus 12(12):891–896PubMedCrossRef Graham JW, Jan W (2003) MRI and the brain in systemic lupus erythematosus. Lupus 12(12):891–896PubMedCrossRef
99.
Zurück zum Zitat Boumpas DT, Patronas NJ, Dalakas MC, Hakim CA, Klippel JH, Balow JE (1990) Acute transverse myelitis in systemic lupus erythematosus: magnetic resonance imaging and review of the literature. J Rheumatol 17(1):89–92PubMed Boumpas DT, Patronas NJ, Dalakas MC, Hakim CA, Klippel JH, Balow JE (1990) Acute transverse myelitis in systemic lupus erythematosus: magnetic resonance imaging and review of the literature. J Rheumatol 17(1):89–92PubMed
100.
Zurück zum Zitat Salmaggi A, Lamperti E, Eoli M, Venegoni E, Bruzzone MG, Riccio G, La Mantia L (1994) Spinal cord involvement and systemic lupus erythematosus: clinical and magnetic resonance findings in 5 patients. Clin Exp Rheumatol 12(4):389–394PubMed Salmaggi A, Lamperti E, Eoli M, Venegoni E, Bruzzone MG, Riccio G, La Mantia L (1994) Spinal cord involvement and systemic lupus erythematosus: clinical and magnetic resonance findings in 5 patients. Clin Exp Rheumatol 12(4):389–394PubMed
101.
Zurück zum Zitat Trevisani VF, Castro AA, Neves Neto JF, Atallah AN (2006) Cyclophosphamide versus methylprednisolone for treating neuropsychiatric involvement in systemic lupus erythematosus. Cochrane Database Syst Rev 2:CD002265. doi:10.1002/14651858.CD002265.pub2 PubMed Trevisani VF, Castro AA, Neves Neto JF, Atallah AN (2006) Cyclophosphamide versus methylprednisolone for treating neuropsychiatric involvement in systemic lupus erythematosus. Cochrane Database Syst Rev 2:CD002265. doi:10.​1002/​14651858.​CD002265.​pub2 PubMed
102.
Zurück zum Zitat Barile-Fabris L, Ariza-Andraca R, Olguin-Ortega L, Jara LJ, Fraga-Mouret A, Miranda-Limon JM, Fuentes de la Mata J, Clark P, Vargas F, Alocer-Varela J (2005) Controlled clinical trial of IV cyclophosphamide versus IV methylprednisolone in severe neurological manifestations in systemic lupus erythematosus. Ann Rheum Dis 64(4):620–625. doi:10.1136/ard.2004.025528 PubMedCrossRef Barile-Fabris L, Ariza-Andraca R, Olguin-Ortega L, Jara LJ, Fraga-Mouret A, Miranda-Limon JM, Fuentes de la Mata J, Clark P, Vargas F, Alocer-Varela J (2005) Controlled clinical trial of IV cyclophosphamide versus IV methylprednisolone in severe neurological manifestations in systemic lupus erythematosus. Ann Rheum Dis 64(4):620–625. doi:10.​1136/​ard.​2004.​025528 PubMedCrossRef
103.
Zurück zum Zitat Fortin PR, Abrahamowicz M, Ferland D, Lacaille D, Smith CD, Zummer M (2008) Steroid-sparing effects of methotrexate in systemic lupus erythematosus: a double-blind, randomized, placebo-controlled trial. Arthritis Rheum 59(12):1796–1804. doi:10.1002/art.24068 PubMedCrossRef Fortin PR, Abrahamowicz M, Ferland D, Lacaille D, Smith CD, Zummer M (2008) Steroid-sparing effects of methotrexate in systemic lupus erythematosus: a double-blind, randomized, placebo-controlled trial. Arthritis Rheum 59(12):1796–1804. doi:10.​1002/​art.​24068 PubMedCrossRef
104.
Zurück zum Zitat Walsh M, James M, Jayne D, Tonelli M, Manns BJ, Hemmelgarn BR (2007) Mycophenolate mofetil for induction therapy of lupus nephritis: a systematic review and meta-analysis. Clin J Am Soc Nephrol 2(5):968–975. doi:10.2215/CJN.01200307 PubMedCrossRef Walsh M, James M, Jayne D, Tonelli M, Manns BJ, Hemmelgarn BR (2007) Mycophenolate mofetil for induction therapy of lupus nephritis: a systematic review and meta-analysis. Clin J Am Soc Nephrol 2(5):968–975. doi:10.​2215/​CJN.​01200307 PubMedCrossRef
105.
Zurück zum Zitat Perry A, Vuitch F (1995) Causes of death in patients with sarcoidosis: a morphologic study of 38 autopsies with clinicopathologic correlations. Arch Pathol Lab Med 119(2):167–172PubMed Perry A, Vuitch F (1995) Causes of death in patients with sarcoidosis: a morphologic study of 38 autopsies with clinicopathologic correlations. Arch Pathol Lab Med 119(2):167–172PubMed
106.
Zurück zum Zitat Chapelon-Abric C (2001) Neurosarcoidosis. Ann Med Interne (Paris) 152(2):113–124 Chapelon-Abric C (2001) Neurosarcoidosis. Ann Med Interne (Paris) 152(2):113–124
107.
108.
Zurück zum Zitat Rybicki BA, Major M, Popovich J Jr, Maliarik MJ, Iannuzzi MC (1997) Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol 145(3):234–241PubMedCrossRef Rybicki BA, Major M, Popovich J Jr, Maliarik MJ, Iannuzzi MC (1997) Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol 145(3):234–241PubMedCrossRef
110.
Zurück zum Zitat Zajicek JP, Scolding NJ, Foster O, Rovaris M, Evanson J, Moseley IF, Scadding JW, Thompson EJ, Chamoun V, Miller DH, McDonald WI, Mitchell D (1999) Central nervous system sarcoidosis–diagnosis and management. Qjm 92(2):103–117PubMedCrossRef Zajicek JP, Scolding NJ, Foster O, Rovaris M, Evanson J, Moseley IF, Scadding JW, Thompson EJ, Chamoun V, Miller DH, McDonald WI, Mitchell D (1999) Central nervous system sarcoidosis–diagnosis and management. Qjm 92(2):103–117PubMedCrossRef
113.
Zurück zum Zitat Stern BJ, Krumholz A, Johns C, Scott P, Nissim J (1985) Sarcoidosis and its neurological manifestations. Arch Neurol 42(9):909–917PubMedCrossRef Stern BJ, Krumholz A, Johns C, Scott P, Nissim J (1985) Sarcoidosis and its neurological manifestations. Arch Neurol 42(9):909–917PubMedCrossRef
114.
Zurück zum Zitat Cohen-Aubart F, Galanaud D, Grabli D, Haroche J, Amoura Z, Chalpelon-Abric C, Lyon-Caen O, Valeyre D, Piette JC (2010) Spinal cord sarcoidosis: clinical and laboratory profile and outcome of 31 patients in a case-control study. Medicine (Baltimore) 89(2):133–140CrossRef Cohen-Aubart F, Galanaud D, Grabli D, Haroche J, Amoura Z, Chalpelon-Abric C, Lyon-Caen O, Valeyre D, Piette JC (2010) Spinal cord sarcoidosis: clinical and laboratory profile and outcome of 31 patients in a case-control study. Medicine (Baltimore) 89(2):133–140CrossRef
115.
Zurück zum Zitat Dale JC, O’Brien JF (1999) Determination of angiotensin-converting enzyme levels in cerebrospinal fluid is not a useful test for the diagnosis of neurosarcoidosis. Mayo Clin Proc 74(5):535PubMed Dale JC, O’Brien JF (1999) Determination of angiotensin-converting enzyme levels in cerebrospinal fluid is not a useful test for the diagnosis of neurosarcoidosis. Mayo Clin Proc 74(5):535PubMed
116.
Zurück zum Zitat Baughman RP, Iannuzzi MC (2000) Diagnosis of sarcoidosis: when is a peek good enough? Chest 117(4):931–932PubMedCrossRef Baughman RP, Iannuzzi MC (2000) Diagnosis of sarcoidosis: when is a peek good enough? Chest 117(4):931–932PubMedCrossRef
117.
Zurück zum Zitat Kouba DJ, Mimouni D, Rencic A, Nousari HC (2003) Mycophenolate mofetil may serve as a steroid-sparing agent for sarcoidosis. Br J Dermatol 148(1):147–148PubMedCrossRef Kouba DJ, Mimouni D, Rencic A, Nousari HC (2003) Mycophenolate mofetil may serve as a steroid-sparing agent for sarcoidosis. Br J Dermatol 148(1):147–148PubMedCrossRef
118.
Zurück zum Zitat Doty JD, Mazur JE, Judson MA (2003) Treatment of corticosteroid-resistant neurosarcoidosis with a short-course cyclophosphamide regimen. Chest 124(5):2023–2026PubMedCrossRef Doty JD, Mazur JE, Judson MA (2003) Treatment of corticosteroid-resistant neurosarcoidosis with a short-course cyclophosphamide regimen. Chest 124(5):2023–2026PubMedCrossRef
119.
Zurück zum Zitat Carter JD, Valeriano J, Vasey FB, Bognar B (2004) Refractory neurosarcoidosis: a dramatic response to infliximab. Am J Med 117(4):277–279PubMedCrossRef Carter JD, Valeriano J, Vasey FB, Bognar B (2004) Refractory neurosarcoidosis: a dramatic response to infliximab. Am J Med 117(4):277–279PubMedCrossRef
120.
Zurück zum Zitat Duna GF, Calabrese LH (1995) Limitations of invasive modalities in the diagnosis of primary angiitis of the central nervous system. J Rheumatol 22(4):662–667PubMed Duna GF, Calabrese LH (1995) Limitations of invasive modalities in the diagnosis of primary angiitis of the central nervous system. J Rheumatol 22(4):662–667PubMed
121.
Zurück zum Zitat International Study Group for Behçet’s Disease (1990) Criteria for diagnosis of Behçet’s disease. Lancet 335(8697):1078–1080 International Study Group for Behçet’s Disease (1990) Criteria for diagnosis of Behçet’s disease. Lancet 335(8697):1078–1080
122.
123.
Zurück zum Zitat Siva A, Altintas A, Saip S (2004) Behçet’s syndrome and the nervous system. Curr Opin Neurol 17(3):347–357PubMedCrossRef Siva A, Altintas A, Saip S (2004) Behçet’s syndrome and the nervous system. Curr Opin Neurol 17(3):347–357PubMedCrossRef
124.
Zurück zum Zitat Al-Araji A, Kidd DP (2009) Neuro-Behçet’s disease: epidemiology, clinical characteristics, and management. Lancet Neurol 8(2):192–204PubMedCrossRef Al-Araji A, Kidd DP (2009) Neuro-Behçet’s disease: epidemiology, clinical characteristics, and management. Lancet Neurol 8(2):192–204PubMedCrossRef
125.
126.
Zurück zum Zitat Akman-Demir G, Serdaroglu P, Tasci B (1999) Clinical patterns of neurological involvement in Behçet’s disease: evaluation of 200 patients: the Neuro-Behçet study group. Brain 122(Pt 11):2171–2182PubMedCrossRef Akman-Demir G, Serdaroglu P, Tasci B (1999) Clinical patterns of neurological involvement in Behçet’s disease: evaluation of 200 patients: the Neuro-Behçet study group. Brain 122(Pt 11):2171–2182PubMedCrossRef
127.
128.
Zurück zum Zitat Kidd D, Steuer A, Denman AM, Rudge P (1999) Neurological complications in Behçet’s syndrome. Brain 122(Pt 11):2183–2194PubMedCrossRef Kidd D, Steuer A, Denman AM, Rudge P (1999) Neurological complications in Behçet’s syndrome. Brain 122(Pt 11):2183–2194PubMedCrossRef
129.
Zurück zum Zitat Saruhan-Direskeneli G, Yentur SP, Akman-Demir G, Isik N, Serdaroglu P (2003) Cytokines and chemokines in neuro-Behçet’s disease compared to multiple sclerosis and other neurological diseases. J Neuroimmunol 145(1–2):127–134PubMedCrossRef Saruhan-Direskeneli G, Yentur SP, Akman-Demir G, Isik N, Serdaroglu P (2003) Cytokines and chemokines in neuro-Behçet’s disease compared to multiple sclerosis and other neurological diseases. J Neuroimmunol 145(1–2):127–134PubMedCrossRef
130.
Zurück zum Zitat Yazici H, Fresko I, Yurdakul S (2007) Behçet’s syndrome: disease manifestations, management, and advances in treatment. Nat Clin Pract Rheumatol 3(3):148–155PubMedCrossRef Yazici H, Fresko I, Yurdakul S (2007) Behçet’s syndrome: disease manifestations, management, and advances in treatment. Nat Clin Pract Rheumatol 3(3):148–155PubMedCrossRef
131.
Zurück zum Zitat Siva A, Kantarci OH, Saip S, Altintas A, Hamuryudan V, Islak C, Kocer N, Yazici H (2001) Behçet’s disease: diagnostic and prognostic aspects of neurological involvement. J Neurol 248(2):95–103PubMedCrossRef Siva A, Kantarci OH, Saip S, Altintas A, Hamuryudan V, Islak C, Kocer N, Yazici H (2001) Behçet’s disease: diagnostic and prognostic aspects of neurological involvement. J Neurol 248(2):95–103PubMedCrossRef
132.
Zurück zum Zitat Kocer N, Islak C, Siva A, Saip S, Akman C, Kantarci O, Hamuryudan V (1999) CNS involvement in neuro-Behçet syndrome: an MR study. AJNR Am J Neuroradiol 20(6):1015–1024PubMed Kocer N, Islak C, Siva A, Saip S, Akman C, Kantarci O, Hamuryudan V (1999) CNS involvement in neuro-Behçet syndrome: an MR study. AJNR Am J Neuroradiol 20(6):1015–1024PubMed
133.
Zurück zum Zitat Yesilot N, Mutlu M, Gungor O, Baykal B, Serdaroglu P, Akman-Demir G (2007) Clinical characteristics and course of spinal cord involvement in Behçet’s disease. Eur J Neurol 14(7):729–737PubMedCrossRef Yesilot N, Mutlu M, Gungor O, Baykal B, Serdaroglu P, Akman-Demir G (2007) Clinical characteristics and course of spinal cord involvement in Behçet’s disease. Eur J Neurol 14(7):729–737PubMedCrossRef
134.
Zurück zum Zitat Kidd D, Beynon HL (2003) The neurological complications of systemic sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 20(2):85–94PubMed Kidd D, Beynon HL (2003) The neurological complications of systemic sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 20(2):85–94PubMed
135.
Zurück zum Zitat Kikuchi H, Aramaki K, Hirohata S (2008) Effect of infliximab in progressive neuro-Behçet’s syndrome. J Neurol Sci 272(1–2):99–105PubMedCrossRef Kikuchi H, Aramaki K, Hirohata S (2008) Effect of infliximab in progressive neuro-Behçet’s syndrome. J Neurol Sci 272(1–2):99–105PubMedCrossRef
136.
137.
Zurück zum Zitat Salvarani C, Brown RD Jr, Calamia KT, Christianson TJ, Weigand SD, Miller DV, Giannini C, Meschia JF, Huston J 3rd, Hunder GG (2007) Primary central nervous system vasculitis: analysis of 101 patients. Ann Neurol 62(5):442–451PubMedCrossRef Salvarani C, Brown RD Jr, Calamia KT, Christianson TJ, Weigand SD, Miller DV, Giannini C, Meschia JF, Huston J 3rd, Hunder GG (2007) Primary central nervous system vasculitis: analysis of 101 patients. Ann Neurol 62(5):442–451PubMedCrossRef
138.
Zurück zum Zitat Benseler S, Schneider R (2004) Central nervous system vasculitis in children. Curr Opin Rheumatol 16(1):43–50PubMedCrossRef Benseler S, Schneider R (2004) Central nervous system vasculitis in children. Curr Opin Rheumatol 16(1):43–50PubMedCrossRef
140.
Zurück zum Zitat Calabrese LH, Duna GF, Lie JT (1997) Vasculitis in the central nervous system. Arthritis Rheum 40(7):1189–1201PubMed Calabrese LH, Duna GF, Lie JT (1997) Vasculitis in the central nervous system. Arthritis Rheum 40(7):1189–1201PubMed
141.
Zurück zum Zitat Salvarani C, Brown RD Jr, Calamia KT, Christianson TJ, Huston J 3rd, Meschia JF, Giannini C, Miller DV, Hunder GG (2008) Primary central nervous system vasculitis: comparison of patients with and without cerebral amyloid angiopathy. Rheumatology (Oxford) 47(11):1671–1677CrossRef Salvarani C, Brown RD Jr, Calamia KT, Christianson TJ, Huston J 3rd, Meschia JF, Giannini C, Miller DV, Hunder GG (2008) Primary central nervous system vasculitis: comparison of patients with and without cerebral amyloid angiopathy. Rheumatology (Oxford) 47(11):1671–1677CrossRef
142.
Zurück zum Zitat Lie JT (1992) Primary (granulomatous) angiitis of the central nervous system: a clinicopathologic analysis of 15 new cases and a review of the literature. Hum Pathol 23(2):164–171PubMedCrossRef Lie JT (1992) Primary (granulomatous) angiitis of the central nervous system: a clinicopathologic analysis of 15 new cases and a review of the literature. Hum Pathol 23(2):164–171PubMedCrossRef
143.
Zurück zum Zitat Pomper MG, Miller TJ, Stone JH, Tidmore WC, Hellmann DB (1999) CNS vasculitis in autoimmune disease: MR imaging findings and correlation with angiography. AJNR Am J Neuroradiol 20(1):75–85PubMed Pomper MG, Miller TJ, Stone JH, Tidmore WC, Hellmann DB (1999) CNS vasculitis in autoimmune disease: MR imaging findings and correlation with angiography. AJNR Am J Neuroradiol 20(1):75–85PubMed
144.
Zurück zum Zitat Harris KG, Tran DD, Sickels WJ, Cornell SH, Yuh WT (1994) Diagnosing intracranial vasculitis: the roles of MR and angiography. AJNR Am J Neuroradiol 15(2):317–330PubMed Harris KG, Tran DD, Sickels WJ, Cornell SH, Yuh WT (1994) Diagnosing intracranial vasculitis: the roles of MR and angiography. AJNR Am J Neuroradiol 15(2):317–330PubMed
145.
Zurück zum Zitat Calabrese LH (2003) Clinical management issues in vasculitis: angiographically defined angiitis of the central nervous system—diagnostic and therapeutic dilemmas. Clin Exp Rheumatol 21(6 Suppl 32):S127–S130PubMed Calabrese LH (2003) Clinical management issues in vasculitis: angiographically defined angiitis of the central nervous system—diagnostic and therapeutic dilemmas. Clin Exp Rheumatol 21(6 Suppl 32):S127–S130PubMed
146.
Zurück zum Zitat Vollmer TL, Guarnaccia J, Harrington W, Pacia SV, Petroff OA (1993) Idiopathic granulomatous angiitis of the central nervous system: diagnostic challenges. Arch Neurol 50(9):925–930PubMedCrossRef Vollmer TL, Guarnaccia J, Harrington W, Pacia SV, Petroff OA (1993) Idiopathic granulomatous angiitis of the central nervous system: diagnostic challenges. Arch Neurol 50(9):925–930PubMedCrossRef
147.
Zurück zum Zitat Birnbaum J, Hellmann DB (2009) Primary angiitis of the central nervous system. Arch Neurol 66(6):704–709PubMedCrossRef Birnbaum J, Hellmann DB (2009) Primary angiitis of the central nervous system. Arch Neurol 66(6):704–709PubMedCrossRef
148.
Zurück zum Zitat Levy JA, Shimabukuro J, Hollander H, Mills J, Kaminsky L (1985) Isolation of AIDS-associated retroviruses from cerebrospinal fluid and brain of patients with neurological symptoms. Lancet 2(8455):586–588PubMed Levy JA, Shimabukuro J, Hollander H, Mills J, Kaminsky L (1985) Isolation of AIDS-associated retroviruses from cerebrospinal fluid and brain of patients with neurological symptoms. Lancet 2(8455):586–588PubMed
Metadaten
Titel
A differential diagnosis of central nervous system demyelination: beyond multiple sclerosis
verfasst von
Christopher Eckstein
Shiv Saidha
Michael Levy
Publikationsdatum
01.05.2012
Verlag
Springer-Verlag
Erschienen in
Journal of Neurology / Ausgabe 5/2012
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-011-6240-5

Weitere Artikel der Ausgabe 5/2012

Journal of Neurology 5/2012 Zur Ausgabe

Pioneers in Neurology

Rhazes (865–925 AD)

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.